Medication adherence in systemic lupus erythematosus during Brazilian COVID-19 pandemic.

ABSTRACT:

Background

Patients with chronic diseases are potential candidates for inadequate follow-up of drug therapy, tending to incur damage to the intended results. This deserves greater attention in the pandemic period, as they are in the considered risk group.

Methods

We aim to assess Treatment Adherence Measure and analyze associations with characteristics related to the patient, treatment, disease, health professionals and service, and sociodemographic issues in patients with Systemic Lupus Erythematosus (SLE). W conducted a cross-sectional study with a sample of 116 participants, whose data were collected through individual interviews and review of medical records, during the first months of the COVID-19 pandemic in Brazil. Adherence was measured using the Treatment Adherence

SUBMITTER: Albuquerque ES 

PROVIDER: S-EPMC8792910 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature